Health Care & Life Sciences » Pharmaceuticals | Pulike Biological Engineering Inc.

Pulike Biological Engineering Inc. | Balance Sheet

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
168
214
791
944
964
746
Total Accounts Receivable
84
122
112
117
114
150
Inventories
53
53
60
62
71
97
Other Current Assets
3
4
3
3
2
10
Total Current Assets
308
391
966
1,125
1,152
1,003
Net Property, Plant & Equipment
293
294
291
334
369
367
Total Investments and Advances
6
6
7
42
59
290
Intangible Assets
121
115
231
215
208
220
Other Assets
2
30
8
19
16
20
Total Assets
731
838
1,504
1,737
1,805
1,903
ST Debt & Current Portion LT Debt
-
-
-
46
27
Accounts Payable
41
31
21
28
29
Income Tax Payable
2
1
2
6
2
Other Current Liabilities
75
94
119
144
148
Total Current Liabilities
119
126
142
224
207
Deferred Taxes
1
1
1
2
2
Total Liabilities
119
126
142
224
207
Common Equity (Total)
603
684
1,337
1,481
1,569
Total Shareholders' Equity
603
684
1,337
1,481
1,569
Total Equity
603
684
1,337
1,481
1,569
Liabilities & Shareholders' Equity
731
838
1,504
1,737
1,805
Non-Equity Reserves
9
29
24
32
30

About Pulike Biological Engineering

View Profile
Address
No. 15 Zhenghe Road
Luoyang Henan 471000
China
Employees -
Website http://www.pulike.com.cn
Updated 07/08/2019
Pulike Biological Engineering, Inc. engages in the research & development, manufacture and sale of veterinary bio-products. Its products include industrialization products, vaccine products and medicines. The company was founded on January 1, 1995 and is headquartered in Luoyang, China.